EXTREME PCR

European patent · EP2855692 · In force

Register entry

Publication number
EP2855692
Application number
EP13793389
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 23, 2013
Published
Apr 8, 2015
Granted
Jul 24, 2019
Protection ends at the latest
May 22, 2033
Next annual fee due
May 31, 2027
IPC classes
C12Q 1/686 (2018.01)
B01L 7/00 (2006.01)
B01L 7/02 (2006.01)
B01L 3/00 (2006.01)
Priority
US 201261651161 P 24.05.2012
US 201361811145 P 12.04.2013
PCT application
PCT/US2013/042473 23.05.2013
PCT publication
WO2013/177429 28.11.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 9, 2023

    Change

    Published in Swissreg on 09.06.2023

  5. May 8, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.05.2023

  6. Sep 11, 2019

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 11.09.2019

  7. Jul 24, 2019

    Granted

    Published in Swissreg on 24.07.2019

Parties

Holder

University of Utah Research Foundation

590 Wakara Way, Salt Lake City, UT 84108, US

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

WITTWER, Carl, T.

Salt Lake City, UT 84109, US

FARRAR, Jared, Steven

Salt Lake City, UT 84104, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.